-
1
-
-
13444253765
-
Efficacy and safety of infliximab in patients with ankylosing spondylitis: results of a randomized, placebo-controlled trial (ASSERT)
-
10.1002/art.20852, 15692973
-
van der Heijde D, Dijkmans B, Geusens P, Sieper J, DeWoody K, Williamson P, Braun J. Efficacy and safety of infliximab in patients with ankylosing spondylitis: results of a randomized, placebo-controlled trial (ASSERT). Arthritis Rheum 2005, 52:582-591. 10.1002/art.20852, 15692973.
-
(2005)
Arthritis Rheum
, vol.52
, pp. 582-591
-
-
van der Heijde, D.1
Dijkmans, B.2
Geusens, P.3
Sieper, J.4
DeWoody, K.5
Williamson, P.6
Braun, J.7
-
2
-
-
34147195656
-
No efficacy of subcutaneous methotrexate in active ankylosing spondylitis: a 16-week open-label trial
-
10.1136/ard.2006.054098, 1856012, 16901959
-
Haibel H, Brandt HC, Song IH, Brandt A, Listing J, Rudwaleit M, Sieper J. No efficacy of subcutaneous methotrexate in active ankylosing spondylitis: a 16-week open-label trial. Ann Rheum Dis 2007, 66:419-421. 10.1136/ard.2006.054098, 1856012, 16901959.
-
(2007)
Ann Rheum Dis
, vol.66
, pp. 419-421
-
-
Haibel, H.1
Brandt, H.C.2
Song, I.H.3
Brandt, A.4
Listing, J.5
Rudwaleit, M.6
Sieper, J.7
-
3
-
-
0034769918
-
Clinical investigation of methotrexate in the treatment of ankylosing spondylitis
-
10.1080/030097401753180318, 11727838
-
Altan L, Bingol U, Karakoc Y, Aydiner S, Yurtkuran M, Yurtkuran M. Clinical investigation of methotrexate in the treatment of ankylosing spondylitis. Scand J Rheumatol 2001, 30:255-259. 10.1080/030097401753180318, 11727838.
-
(2001)
Scand J Rheumatol
, vol.30
, pp. 255-259
-
-
Altan, L.1
Bingol, U.2
Karakoc, Y.3
Aydiner, S.4
Yurtkuran, M.5
Yurtkuran, M.6
-
4
-
-
3442880132
-
Efficacy of methotrexate in ankylosing spondylitis: a randomized, double blind, placebo controlled trial
-
Gonzalez-Lopez L, Garcia-Gonzalez A, Vazquez-Del-Mercado M, Muñoz-Valle JF, Gamez-Nava JI. Efficacy of methotrexate in ankylosing spondylitis: a randomized, double blind, placebo controlled trial. J Rheumatol 2004, 31:1568-1574.
-
(2004)
J Rheumatol
, vol.31
, pp. 1568-1574
-
-
Gonzalez-Lopez, L.1
Garcia-Gonzalez, A.2
Vazquez-Del-Mercado, M.3
Muñoz-Valle, J.F.4
Gamez-Nava, J.I.5
-
5
-
-
0036852327
-
Is methotrexate effective in ankylosing spondylitis?
-
Roychowdhury B, Bintley-Bagot S, Bulgen DY, Thompson RN, Tunn EJ, Moots RJ. Is methotrexate effective in ankylosing spondylitis?. Rheumatology (Oxford) 2002, 41:1330-1332.
-
(2002)
Rheumatology (Oxford)
, vol.41
, pp. 1330-1332
-
-
Roychowdhury, B.1
Bintley-Bagot, S.2
Bulgen, D.Y.3
Thompson, R.N.4
Tunn, E.J.5
Moots, R.J.6
-
7
-
-
34248232034
-
Increased efficacy of infliximab associated with methotrexate in ankylosing spondylitis
-
10.1016/j.jbspin.2006.08.005, 17387031
-
Pérez-Guijo VC, Cravo AR, Castro Mdel C, Font P, Muñoz-Gomariz E, Collantes-Estevez E. Increased efficacy of infliximab associated with methotrexate in ankylosing spondylitis. Joint Bone Spine 2007, 74:254-258. 10.1016/j.jbspin.2006.08.005, 17387031.
-
(2007)
Joint Bone Spine
, vol.74
, pp. 254-258
-
-
Pérez-Guijo, V.C.1
Cravo, A.R.2
Castro Mdel, C.3
Font, P.4
Muñoz-Gomariz, E.5
Collantes-Estevez, E.6
-
8
-
-
38149024172
-
Maintenance of infliximab treatment in ankylosing spondylitis: results of a one-year randomized controlled trial comparing systematic versus on-demand treatment
-
10.1002/art.23167, 18163509, French Ankylosing Spondylitis Infliximab Network
-
Breban M, Ravaud P, Claudepierre P, Baron G, Henry YD, Hudry C, Euller-Ziegler L, Pham T, Solau-Gervais E, Chary-Valckenaere I, Marcelli C, Perdriger A, Le Loët X, Wendling D, Fautrel B, Fournié B, Combe B, Gaudin P, Jousse S, Mariette X, Baleydier A, Trape G, Dougados M, . French Ankylosing Spondylitis Infliximab Network Maintenance of infliximab treatment in ankylosing spondylitis: results of a one-year randomized controlled trial comparing systematic versus on-demand treatment. Arthritis Rheum 2008, 58:88-97. 10.1002/art.23167, 18163509, French Ankylosing Spondylitis Infliximab Network.
-
(2008)
Arthritis Rheum
, vol.58
, pp. 88-97
-
-
Breban, M.1
Ravaud, P.2
Claudepierre, P.3
Baron, G.4
Henry, Y.D.5
Hudry, C.6
Euller-Ziegler, L.7
Pham, T.8
Solau-Gervais, E.9
Chary-Valckenaere, I.10
Marcelli, C.11
Perdriger, A.12
Le Loët, X.13
Wendling, D.14
Fautrel, B.15
Fournié, B.16
Combe, B.17
Gaudin, P.18
Jousse, S.19
Mariette, X.20
Baleydier, A.21
Trape, G.22
Dougados, M.23
more..
-
9
-
-
36849016433
-
Recommendations of the French Society for Rheumatology regarding TNFα antagonist therapy in patients with ankylosing spondylitis or psoriatic arthritis: 2007 update
-
10.1016/j.jbspin.2007.10.003, 18065252, Club Rhumatismes et Inflammation (CRI/SFR)
-
Pham T, Fautrel B, Dernis E, Goupille P, Guillemin F, Le Loët X, Ravaud P, Claudepierre P, Miceli-Richard C, de Bandt M, Breban M, Maillefert JF, Masson C, Saraux A, Schaeverbeke T, Wendling D, Mariette X, Combe B, . Club Rhumatismes et Inflammation (CRI/SFR) Recommendations of the French Society for Rheumatology regarding TNFα antagonist therapy in patients with ankylosing spondylitis or psoriatic arthritis: 2007 update. Joint Bone Spine 2007, 74:638-646. 10.1016/j.jbspin.2007.10.003, 18065252, Club Rhumatismes et Inflammation (CRI/SFR).
-
(2007)
Joint Bone Spine
, vol.74
, pp. 638-646
-
-
Pham, T.1
Fautrel, B.2
Dernis, E.3
Goupille, P.4
Guillemin, F.5
Le Loët, X.6
Ravaud, P.7
Claudepierre, P.8
Miceli-Richard, C.9
de Bandt, M.10
Breban, M.11
Maillefert, J.F.12
Masson, C.13
Saraux, A.14
Schaeverbeke, T.15
Wendling, D.16
Mariette, X.17
Combe, B.18
-
10
-
-
0021272107
-
Evaluation of diagnostic criteria for ankylosing spondylitis: a proposal for modification of the New York criteria
-
10.1002/art.1780270401, 6231933
-
van der Linden S, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis: a proposal for modification of the New York criteria. Arthritis Rheum 1984, 27:361-368. 10.1002/art.1780270401, 6231933.
-
(1984)
Arthritis Rheum
, vol.27
, pp. 361-368
-
-
van der Linden, S.1
Valkenburg, H.A.2
Cats, A.3
-
11
-
-
0038423033
-
International ASAS consensus statement for the use of anti-tumour necrosis factor agents in patients with ankylosing spondylitis
-
10.1136/ard.62.9.817, 1754665, 12922952
-
Braun J, Pham T, Sieper J, Davis J, van der Linden S, Dougados M, van der Heijde D. International ASAS consensus statement for the use of anti-tumour necrosis factor agents in patients with ankylosing spondylitis. Ann Rheum Dis 2003, 62:817-824. 10.1136/ard.62.9.817, 1754665, 12922952.
-
(2003)
Ann Rheum Dis
, vol.62
, pp. 817-824
-
-
Braun, J.1
Pham, T.2
Sieper, J.3
Davis, J.4
van der Linden, S.5
Dougados, M.6
van der Heijde, D.7
-
12
-
-
33748193708
-
An enzyme-linked immunosorbent assay for therapeutic drug monitoring of infliximab
-
10.1097/01.ftd.0000189901.08684.4b, 16628126
-
Ternant D, Mulleman D, Degenne D, Willot S, Guillaumin JM, Watier H, Goupille P, Paintaud G. An enzyme-linked immunosorbent assay for therapeutic drug monitoring of infliximab. Ther Drug Monit 2006, 28:169-174. 10.1097/01.ftd.0000189901.08684.4b, 16628126.
-
(2006)
Ther Drug Monit
, vol.28
, pp. 169-174
-
-
Ternant, D.1
Mulleman, D.2
Degenne, D.3
Willot, S.4
Guillaumin, J.M.5
Watier, H.6
Goupille, P.7
Paintaud, G.8
-
13
-
-
80055091440
-
The R Project for Statistical Computing
-
The R Project for Statistical Computing. , http://www.R-project.org/
-
-
-
-
14
-
-
66249104338
-
Circulating concentration of infliximab and response to treatment in ankylosing spondylitis: results from a randomized control study
-
10.1002/art.24275, 19405015, French Ankylosing Spondylitis Infliximab Network
-
Krzysiek R, Breban M, Ravaud P, Prejean MV, Wijdenes J, Roy C, Henry YD, Barbey C, Trappe G, Dougados M, Emilie D, . French Ankylosing Spondylitis Infliximab Network Circulating concentration of infliximab and response to treatment in ankylosing spondylitis: results from a randomized control study. Arthritis Rheum 2009, 61:569-576. 10.1002/art.24275, 19405015, French Ankylosing Spondylitis Infliximab Network.
-
(2009)
Arthritis Rheum
, vol.61
, pp. 569-576
-
-
Krzysiek, R.1
Breban, M.2
Ravaud, P.3
Prejean, M.V.4
Wijdenes, J.5
Roy, C.6
Henry, Y.D.7
Barbey, C.8
Trappe, G.9
Dougados, M.10
Emilie, D.11
-
15
-
-
67549096874
-
Multinational evidence-based recommendations for the use of methotrexate in rheumatic disorders with a focus on rheumatoid arthritis: integrating systematic literature research and expert opinion of a broad international panel of rheumatologists in the 3E Initiative
-
10.1136/ard.2008.094474, 2689523, 19033291
-
Visser K, Katchamart W, Loza E, Martinez-Lopez JA, Salliot C, Trudeau J, Bombardier C, Carmona L, van der Heijde D, Bijlsma JW, Boumpas DT, Canhao H, Edwards CJ, Hamuryudan V, Kvien TK, Leeb BF, Martín-Mola EM, Mielants H, Müller-Ladner U, Murphy G, Østergaard M, Pereira IA, Ramos-Remus C, Valentini G, Zochling J, Dougados M. Multinational evidence-based recommendations for the use of methotrexate in rheumatic disorders with a focus on rheumatoid arthritis: integrating systematic literature research and expert opinion of a broad international panel of rheumatologists in the 3E Initiative. Ann Rheum Dis 2009, 68:1086-1093. 10.1136/ard.2008.094474, 2689523, 19033291.
-
(2009)
Ann Rheum Dis
, vol.68
, pp. 1086-1093
-
-
Visser, K.1
Katchamart, W.2
Loza, E.3
Martinez-Lopez, J.A.4
Salliot, C.5
Trudeau, J.6
Bombardier, C.7
Carmona, L.8
van der Heijde, D.9
Bijlsma, J.W.10
Boumpas, D.T.11
Canhao, H.12
Edwards, C.J.13
Hamuryudan, V.14
Kvien, T.K.15
Leeb, B.F.16
Martín-Mola, E.M.17
Mielants, H.18
Müller-Ladner, U.19
Murphy, G.20
Østergaard, M.21
Pereira, I.A.22
Ramos-Remus, C.23
Valentini, G.24
Zochling, J.25
Dougados, M.26
more..
-
16
-
-
34548192177
-
Decreased clinical response to infliximab in ankylosing spondylitis is correlated with anti-infliximab formation
-
10.1136/ard.2007.072397, 1955152, 17472991
-
de Vries MK, Wolbink GJ, Stapel SO, de Vrieze H, van Denderen JC, Dijkmans BA, Aarden LA, van der Horst-Bruinsma IE. Decreased clinical response to infliximab in ankylosing spondylitis is correlated with anti-infliximab formation. Ann Rheum Dis 2007, 66:1252-1254. 10.1136/ard.2007.072397, 1955152, 17472991.
-
(2007)
Ann Rheum Dis
, vol.66
, pp. 1252-1254
-
-
de Vries, M.K.1
Wolbink, G.J.2
Stapel, S.O.3
de Vrieze, H.4
van Denderen, J.C.5
Dijkmans, B.A.6
Aarden, L.A.7
van der Horst-Bruinsma, I.E.8
-
17
-
-
0031660364
-
Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor α monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis
-
10.1002/1529-0131(199809)41:9<1552::AID-ART5>3.0.CO;2-W, 9751087
-
Maini RN, Breedveld FC, Kalden JR, Smolen JS, Davis D, Macfarlane JD, Antoni C, Leeb B, Elliott MJ, Woody JN, Schaible TF, Feldmann M. Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor α monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis. Arthritis Rheum 1998, 41:1552-1563. 10.1002/1529-0131(199809)41:9<1552::AID-ART5>3.0.CO;2-W, 9751087.
-
(1998)
Arthritis Rheum
, vol.41
, pp. 1552-1563
-
-
Maini, R.N.1
Breedveld, F.C.2
Kalden, J.R.3
Smolen, J.S.4
Davis, D.5
Macfarlane, J.D.6
Antoni, C.7
Leeb, B.8
Elliott, M.J.9
Woody, J.N.10
Schaible, T.F.11
Feldmann, M.12
-
18
-
-
0037018761
-
Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial
-
10.1016/S0140-6736(02)08512-4, 12047962
-
Hanauer SB, Feagan BG, Lichtenstein GR, Mayer LF, Schreiber S, Colombel JF, Rachmilewitz D, Wolf DC, Olson A, Bao W, Rutgeerts P. Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial. Lancet 2002, 359:1541-1549. 10.1016/S0140-6736(02)08512-4, 12047962.
-
(2002)
Lancet
, vol.359
, pp. 1541-1549
-
-
Hanauer, S.B.1
Feagan, B.G.2
Lichtenstein, G.R.3
Mayer, L.F.4
Schreiber, S.5
Colombel, J.F.6
Rachmilewitz, D.7
Wolf, D.C.8
Olson, A.9
Bao, W.10
Rutgeerts, P.11
-
19
-
-
0037434552
-
Influence of immunogenicity on the long-term efficacy of infliximab in Crohn's disease
-
10.1056/NEJMoa020888, 12584368
-
Baert F, Noman M, Vermeire S, Van Assche G, D' Haens G, Carbonez A, Rutgeerts P. Influence of immunogenicity on the long-term efficacy of infliximab in Crohn's disease. N Engl J Med 2003, 348:601-608. 10.1056/NEJMoa020888, 12584368.
-
(2003)
N Engl J Med
, vol.348
, pp. 601-608
-
-
Baert, F.1
Noman, M.2
Vermeire, S.3
Van Assche, G.4
D' Haens, G.5
Carbonez, A.6
Rutgeerts, P.7
-
20
-
-
33845660797
-
Individualized monitoring of drug bioavailability and immunogenicity in rheumatoid arthritis patients treated with the tumor necrosis factor alpha inhibitor infliximab
-
10.1002/art.22214, 17133559
-
Bendtzen K, Geborek P, Svenson M, Larsson L, Kapetanovic MC, Saxne T. Individualized monitoring of drug bioavailability and immunogenicity in rheumatoid arthritis patients treated with the tumor necrosis factor alpha inhibitor infliximab. Arthritis Rheum 2006, 54:3782-3789. 10.1002/art.22214, 17133559.
-
(2006)
Arthritis Rheum
, vol.54
, pp. 3782-3789
-
-
Bendtzen, K.1
Geborek, P.2
Svenson, M.3
Larsson, L.4
Kapetanovic, M.C.5
Saxne, T.6
-
21
-
-
17644382690
-
Relationship between serum trough infliximab levels, pretreatment C reactive protein levels, and clinical response to infliximab treatment in patients with rheumatoid arthritis
-
10.1136/ard.2004.030452, 1755482, 15485995
-
Wolbink GJ, Voskuyl AE, Lems WF, de Groot E, Nurmohamed MT, Tak PP, Dijkmans BA, Aarden L. Relationship between serum trough infliximab levels, pretreatment C reactive protein levels, and clinical response to infliximab treatment in patients with rheumatoid arthritis. Ann Rheum Dis 2005, 64:704-707. 10.1136/ard.2004.030452, 1755482, 15485995.
-
(2005)
Ann Rheum Dis
, vol.64
, pp. 704-707
-
-
Wolbink, G.J.1
Voskuyl, A.E.2
Lems, W.F.3
de Groot, E.4
Nurmohamed, M.T.5
Tak, P.P.6
Dijkmans, B.A.7
Aarden, L.8
|